10 Best Growth Stocks to Buy With Highest Upside Potential
On April 9, Tom Lee, Head of Research at Fundstrat, appeared on a CNBC Television interview to discuss market conditions as the war between the US and Iran had started to cool down.
Alnylam Pharmaceuticals Inc. (ALNY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 71 | $23,492 | -83% | 0.03% |
| 2. | Sivik Global Healthcare Krishen Sud | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $302.67 | 4 | $1,210.68 | 36 | 2024-10-17 | Filing | |
| $286.00 | 32 | $9,152.00 | 32 | 2024-08-29 | Filing | |
| $71.87 | 297,501 | $21,381,396.87 | 10,554,134 | 2017-05-31 | Filing | |
| $65.35 | 11,500 | $751,502.00 | 11,500 | 2017-05-30 | Filing | |
| $37.00 | 27,900 | $1,032,327.90 | 27,900 | 2016-10-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $333.94 | 199 | $66,454.06 | 9,443 | 2026-04-06 | Filing | |
| $331.89 | 293 | $97,243.77 | 9,642 | 2026-04-06 | Filing | |
| $330.46 | 829 | $273,951.34 | 9,935 | 2026-04-06 | Filing | |
| $329.76 | 909 | $299,751.84 | 10,764 | 2026-04-06 | Filing | |
| $320.14 | 56 | $17,927.84 | 11,673 | 2026-04-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 285,739 | $94,542,463 | 0.68% | |
| 2. | 30,041 | $9,939,665 | 0.17% | |
| 3. | 24,537 | $8,118,557 | 0.2% | |
| 4. | 23,477 | $7,767,835 | 0.1% | |
| 5. | 8,478 | $2,703,108 | 0.01% |
News See All
Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025
ClearBridge Investments, a global equity manager, recently published first-quarter 2026 commentary for its “Large Cap Growth Strategy”. A copy of the letter can be downloaded here.
10 Best Future Stocks to Buy for the Next 5 Years
On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market dynamic.
Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best high growth healthcare stocks to buy now. Alnylam Pharmaceuticals Inc.
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities, and the effects ...
12 Best Rebound Stocks to Buy Right Now
On March 20, oil prices rose again, shaking financial markets as prospects for a central bank interest rate cut in 2026 faded.
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years.
10 Unstoppable Stocks to Buy and Hold for the Next 3 Years
Fundstrat's Tom Lee recently appeared on CNBC Television, highlighting that stocks declined mainly because of the software downturn and a general risk-off as gold surged.
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best NASDAQ growth stocks to buy for the next 2 years.
10 Best NASDAQ Growth Stocks to Buy for the Next 2 Years
On February 19, Tom Lee of Fundstrat and BitMine joined 'Closing Bell' on CNBC to talk about the state of the markets.
Hedge Fund Resource Center